Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2312 (LINC02312) is a long non-coding RNA gene that does not encode a protein but produces a non-coding RNA transcript of more than 200 nucleotides. Such lincRNAs have been characterized as regulatory elements with diverse functions in the cell, notably gene expression regulation (including acting in *cis* or *trans* on other genetic loci), epigenetic modification of chromatin, influencing mRNA processing, and potentially contributing to cell cycle and cell size control. While dysregulation of lncRNAs more broadly is involved in various human diseases, including cancers and metabolic disorders, there is currently no evidence specifically associating LINC02312 with disease nor as a direct therapeutic target. LINC02312 is sometimes cataloged in genomic databases, such as NCBI Gene (Gene ID: 100132612) and Ensembl (ENSG00000258869), but its function and roles remain understudied. There are no known specific drugs, biomarkers, safety concerns, or clinical applications described for this target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2312 (LINC02312).